Descovy Alternatives
Drugs like Descovy (emtricitabine/tenofovir alafenamide) — other hiv medications advertised on TV that may be alternatives. Informational only — not medical advice. Only your doctor can decide what's right for you.
Unverified catalogue summary (alternative grouping) for Descovy in US; not checked against current local product information.
Biktarvy
bictegravir/emtricitabine/tenofovir alafenamide · Gilead Sciences, Inc. (US labeler)
Treats HIV-1 infection
Unverified catalogue summary (alternative identity, manufacturer and indication) for Biktarvy in US; not checked against current local product information.
Cabenuva
cabotegravir/rilpivirine · ViiV Healthcare
Treats HIV-1 infection
Unverified catalogue summary (alternative identity, manufacturer and indication) for Cabenuva in US; not checked against current local product information.
Apretude
cabotegravir · ViiV Healthcare
Treats HIV prevention (PrEP)
Unverified catalogue summary (alternative identity, manufacturer and indication) for Apretude in US; not checked against current local product information.
Sunlenca
lenacapavir · Gilead Sciences
Treats Multidrug-resistant HIV
Unverified catalogue summary (alternative identity, manufacturer and indication) for Sunlenca in US; not checked against current local product information.
Sources and editorial standards
Product-label references, not clinical verification. Medicine identification—not prescribing guidance. This page does not provide a complete safety or dosing reference. Check the official label for your country and exact product, and consult your pharmacist or prescriber before starting, stopping or changing treatment. Missing information does not mean a medicine is safe for you. Reference formulation scope (not dosing instructions): oral emtricitabine/tenofovir alafenamide tablets; 200/25 mg treatment/PrEP and 120/15 mg pediatric treatment strengths distinguished
Unresolved / not established by these sources:
- Clinical summaries, safety tiers and dosing guidance are withheld while their review remains unfinished.
- A linked document may have been superseded. Confirm country, product, formulation and latest revision with the regulator or pharmacist.
- US label reference: Descovy: full US prescribing information, SPL v13, published 2026-07-29
Manufacturer label · Reference scope: Reference link only. Verify the exact formulation and current revision; this does not certify a clinical summary.
- US regulator product record (not a prescribing label): FDA DESCOVY NDA 208215 original approval letter, 2016-04-04
Local licence · Reference scope: Reference link only. Verify the exact formulation and current revision; this does not certify a clinical summary.
Lookup resources (not product-specific citations; confirm formulation and country before use):
Frequently asked questions
What drugs are similar to Descovy?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Drugs like Descovy include other hiv medications advertised on TV such as Biktarvy, Cabenuva, Apretude and more. This is an editorial catalogue grouping, not a verified comparison of indications, safety or suitable substitutes. Ask your prescriber about treatment choices.
What can I take instead of Descovy?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Other hiv medications advertised on TV include Biktarvy, Cabenuva, Apretude and others. The right alternative depends on your diagnosis, medical history and insurance — only your doctor can recommend a substitute for Descovy. This page is informational only.
Is there a generic version of Descovy?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Descovy is sold as emtricitabine/tenofovir alafenamide. Whether a lower-cost generic is available depends on patent status — ask your pharmacist, and see the cost & savings page for ways to pay less.
Are these alternatives the same as Descovy?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. This catalogue grouping does not establish therapeutic equivalence, shared approved indications or suitability as a substitute. Do not switch medicines based on it; consult your prescriber.